Methylprednisolone Administration Following Spinal Cord Injury Reduces Aquaporin 4 Expression and Exacerbates Edema

Mediators of Inflammation, 2017 · DOI: https://doi.org/10.1155/2017/4792932 · Published: May 10, 2017

Simple Explanation

Spinal cord injury (SCI) often leads to edema, or swelling, which can worsen the initial damage. Methylprednisolone (MP) is a drug used to treat SCI, thought to reduce this swelling, but its effectiveness is debated. Aquaporin 4 (AQP4) is a protein that helps regulate water flow in the central nervous system. This study investigates how MP affects AQP4 expression and its role in edema following SCI in rats. The findings suggest that MP, instead of reducing edema, may actually worsen it by reducing the expression of AQP4, which is involved in clearing edema. This supports the movement to avoid using MP for SCI treatment.

Study Duration

24 hours

Participants

Adult male (270–350 g) and female (250–320 g) Long-Evans rats

Evidence Level

Not specified

Key Findings

1
SCI increased AQP4 expression in the spinal cord white matter, and MP diminished this increase to baseline levels.
2
MP increased the extravasation of plasma components after SCI, indicating a more impaired state of the blood-spinal cord barrier.
3
Edema was significantly higher in MP-treated rats subjected to SCI compared to those that received a vehicle.

Research Summary

This study investigates the effects of methylprednisolone (MP) on edema and aquaporin 4 (AQP4) expression in rats following spinal cord injury (SCI). The results indicate that MP, contrary to its intended effect, exacerbates edema and blood-spinal cord barrier disruption by suppressing AQP4 upregulation. The authors conclude that their findings provide scientific evidence against the use of high-dose MP after traumatic SCI, supporting the motion to discontinue its use in clinical practice.

Practical Implications

Clinical Practice

The study supports the movement to discontinue the use of high-dose methylprednisolone in treating acute spinal cord injuries.

Future Research

Further research is needed to understand the mechanisms by which MP enhances blood-spinal cord barrier disruption and exacerbates edema.

Therapeutic Strategies

Alternative therapeutic strategies that do not involve suppressing AQP4 upregulation should be explored to manage edema following SCI.

Study Limitations

1
Assessments were made at a single time point after injury and treatment.
2
Further animal studies are needed to determine the temporal pattern of changes.
3
The mechanism by which MP induced enhanced disruption of the spinal barrier needs to be further elucidated.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury